Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
hypoxia-inducible factor 1 alpha subunit | 5 | 0 | 0 | 5 |
RAR-related orphan receptor gamma | 6 | 0 | 0 | 6 |
GLI family zinc finger 3 | 4 | 0 | 0 | 4 |
AR protein | 8 | 0 | 0 | 8 |
aldehyde dehydrogenase 1 family, member A1 | 4 | 0 | 0 | 4 |
retinoic acid nuclear receptor alpha variant 1 | 6 | 0 | 0 | 6 |
retinoid X nuclear receptor alpha | 6 | 0 | 0 | 6 |
estrogen nuclear receptor alpha | 8 | 0 | 0 | 8 |
peroxisome proliferator-activated receptor delta | 5 | 0 | 0 | 5 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
activating transcription factor 6 | 3 | 0 | 0 | 3 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 4 | 0 | 0 | 4 |
Histone H2A.x | 6 | 0 | 0 | 6 |
thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
heat shock protein beta-1 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 6 | 0 | 0 | 6 |
lamin isoform A-delta10 | 5 | 0 | 0 | 5 |
Voltage-dependent calcium channel gamma-2 subunit | 6 | 0 | 0 | 6 |
Glutamate receptor 2 | 6 | 0 | 0 | 6 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
thioredoxin reductase | 6 | 0 | 0 | 6 |
GALC protein | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 8 | 0 | 0 | 8 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
glucocorticoid receptor [Homo sapiens] | 4 | 0 | 0 | 4 |
estrogen-related nuclear receptor alpha | 7 | 0 | 0 | 7 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
arylsulfatase A | 4 | 0 | 0 | 4 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 5 | 0 | 0 | 5 |
Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
geminin | 4 | 0 | 0 | 4 |
peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
muscleblind-like protein 1 isoform 1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 1 | 1 | 4 |
ATP-binding cassette sub-family C member 3 | 0 | 5 | 0 | 5 |
Multidrug resistance-associated protein 4 | 0 | 5 | 0 | 6 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 12 | 0 | 2 | 1 | 5 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
Bile salt export pump | 0 | 5 | 0 | 5 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Renin | 0 | 2 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 2 | 1 | 7 |
Carbonic anhydrase 2 | 0 | 2 | 2 | 7 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 2 | 1 | 5 |
Cathepsin B | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 1 | 0 | 1 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 3 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
Androgen receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 1 | 1 | 4 |
Translocator protein | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 1 | 1 | 4 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 2 | 1 | 4 |
Carbonic anhydrase 6 | 0 | 2 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 1 | 1 | 4 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 1 | 1 | 4 |
Endochitinase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 1 | 1 | 4 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 1 | 5 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 2 | 1 | 4 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 1 | 1 | 4 |
Cholinesterase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Squalene synthase | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 2 | 1 | 5 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Endochitinase A1 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 2 | 1 | 4 |
GABA theta subunit | 2 | 1 | 1 | 4 |
Canalicular multispecific organic anion transporter 1 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 1 | 1 | 4 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 2 | 1 | 5 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 1 | 5 |
Chain E, Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 3 | 0 | 0 | 3 |
Chain B, HADH2 protein | 3 | 0 | 0 | 3 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
Thymidine kinase | 0 | 1 | 0 | 1 |
phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
GLS protein | 1 | 0 | 0 | 1 |
TDP1 protein | 8 | 0 | 0 | 8 |
Smad3 | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
EWS/FLI fusion protein | 5 | 0 | 0 | 5 |
hemoglobin subunit beta | 2 | 0 | 0 | 2 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 1 |
POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 6 | 0 | 0 | 0 | 2 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 2 |
Thymidine kinase | 0 | 1 | 0 | 1 |
progesterone receptor | 5 | 0 | 0 | 5 |
Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Cellular tumor antigen p53 | 5 | 0 | 0 | 5 |
Amyloid-beta precursor protein | 1 | 1 | 0 | 2 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Luciferase | 1 | 0 | 0 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
endonuclease IV | 1 | 0 | 0 | 1 |
acetylcholinesterase | 2 | 0 | 0 | 2 |
glp-1 receptor, partial | 1 | 0 | 0 | 1 |
Skn7p | 0 | 0 | 0 | 1 |
pregnane X receptor | 1 | 0 | 0 | 1 |
ATAD5 protein, partial | 2 | 0 | 0 | 2 |
Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
Thrombopoietin | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
67.9K protein | 4 | 0 | 0 | 4 |
peroxisome proliferator activated receptor gamma | 4 | 0 | 0 | 4 |
IDH1 | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
thyroid hormone receptor beta isoform 2 | 3 | 0 | 0 | 3 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 2 | 0 | 0 | 2 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
plasminogen precursor | 2 | 0 | 0 | 2 |
urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
Vpr | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 3 | 0 | 3 |
Aromatase | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Ataxin-2 | 2 | 0 | 0 | 2 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
ATP-dependent phosphofructokinase | 3 | 0 | 0 | 3 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
ClpP | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
USP1 protein, partial | 1 | 0 | 0 | 1 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 3 | 0 | 0 | 3 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 2 | 0 | 0 | 2 |
transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
Toll-like receptor 4 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 2 | 4 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Folate receptor beta | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Folate receptor alpha | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Histidine decarboxylase | 0 | 1 | 0 | 1 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 1 | 0 | 0 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Reduced folate transporter | 0 | 2 | 0 | 2 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Caspase-7 | 2 | 0 | 0 | 2 |
Spike glycoprotein | 4 | 0 | 0 | 4 |
Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Pteridine reductase 1 | 0 | 1 | 0 | 1 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 0 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
polyprotein | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
G | 1 | 0 | 0 | 1 |
Interferon beta | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
Chain A, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
Chain B, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
Chain H, Immunoglobulin Igg1 Heavy chain | 0 | 0 | 1 | 1 |
Chain L, Immunoglobulin Igg1 Lambda Light Chain | 0 | 0 | 1 | 1 |
Chain A, DODECIN | 0 | 0 | 1 | 1 |
Chain A, DODECIN | 0 | 0 | 1 | 1 |
Chain C, DODECIN | 0 | 0 | 1 | 1 |
Chain E, DODECIN | 0 | 0 | 1 | 1 |
SMAD family member 2 | 1 | 0 | 0 | 1 |
SMAD family member 3 | 1 | 0 | 0 | 1 |
NPYLR7B | 0 | 0 | 1 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
Riboflavin-binding protein | 0 | 1 | 1 | 2 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |